Nuzenio

Vedanta Biosciences Raises

Vedanta Biosciences Raises news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Vedanta secures $60 million ahead of pivotal Phase III C. difficile data - The Pharma LetterThe Pharma Letter · Fri, 07 Aug 2026 10:43:59 GMTAcrab raises $130M, Sycamore sells Hot Topic and Pregis buys MP Global Packaging - AxiosAxios · Thu, 06 Aug 2026 21:57:18 GMTVedanta Biosciences Raises $60 Million To Advance Phase 3 VE303 Study - Pulse 2.0Pulse 2.0 · Thu, 06 Aug 2026 14:18:46 GMTVedanta Biosciences Raises $60 Million to Advance Phase 3 VE303 Program - citybizcitybiz · Thu, 06 Aug 2026 12:30:53 GMTVedanta Biosciences Raises $60M in Funding - FinSMEsFinSMEs · Thu, 06 Aug 2026 11:28:17 GMTAcrab Raises $130M in Series B Funding - FinSMEsFinSMEs · Thu, 06 Aug 2026 11:26:48 GMTVedanta Biosciences Secures $60 Million in Funding and Strengthens Leadership Team Ahead of Pivotal Phase 3 Data - Business WireBusiness Wire · Thu, 06 Aug 2026 11:00:00 GMTVedanta gets $60M to finish Phase 3 for C. diff microbiome therapy - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 11:00:00 GMT

Timeline

Fri, 07 Aug 2026 10:43:59 GMTVedanta secures $60 million ahead of pivotal Phase III C. difficile data - The Pharma Letter
Thu, 06 Aug 2026 21:57:18 GMTAcrab raises $130M, Sycamore sells Hot Topic and Pregis buys MP Global Packaging - Axios
Thu, 06 Aug 2026 14:18:46 GMTVedanta Biosciences Raises $60 Million To Advance Phase 3 VE303 Study - Pulse 2.0
Thu, 06 Aug 2026 12:30:53 GMTVedanta Biosciences Raises $60 Million to Advance Phase 3 VE303 Program - citybiz
Thu, 06 Aug 2026 11:28:17 GMTVedanta Biosciences Raises $60M in Funding - FinSMEs
Thu, 06 Aug 2026 11:26:48 GMTAcrab Raises $130M in Series B Funding - FinSMEs

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Vedanta Biosciences Raises.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.